Moses Makunje
Finanzdirektor/CFO bei NUVATION BIO INC.
Vermögen: 27 803 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Moses Makunje
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 18 | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Moses Makunje
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Corporate Officer/Principal | |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Chief Executive Officer General Counsel Corporate Officer/Principal | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| Stanford University | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| PROTHENA CORPORATION PLC | Biotechnology | Chairman Director/Board Member | |
| NOVOCURE LIMITED | Medical Specialties | Director/Board Member Director/Board Member | |
| MEDIVATION INC | Pharmaceuticals: Major | Founder Director/Board Member | |
| University of Toledo (Ohio) | College/University | Doctorate Degree Graduate Degree | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | President Sales & Marketing | |
| HALOZYME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chairman | |
| RADIUS HEALTH, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ReCode Therapeutics, Inc.
 ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Pharmaceuticals: Major | Director/Board Member | |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Eastern Michigan University | College/University | Graduate Degree | |
YM Biosciences USA, Inc.
 YM Biosciences USA, Inc. Pharmaceuticals: MajorHealth Technology YM Biosciences USA, Inc. develops and commercializes pharmaceutical products. The company was founded on November 23, 2005 and is headquartered in Wayne, PA. | Pharmaceuticals: Major | General Counsel | |
| The University of Hull | College/University | Undergraduate Degree | |
Topaz Pharmaceuticals, Inc.
 Topaz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Topaz Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on developing and commercializing treatments for the pediatric and dermatology markets. Its lead investigational product is a topical cream formulation of ivermectin which is under development. The firm provides medicines for the treatment of head lice, acne and infections, as well as vaccines against childhood diseases. The company was founded by Donald P. Beeman and Nicholas U. Spring in 2005 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | General Counsel | |
| St. George's University of London | College/University | Doctorate Degree | |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | General Counsel | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | General Counsel | |
Wyeth Research
 Wyeth Research Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Wyeth Research discovers and develops platforms encompassing pharmaceuticals. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GLYCOMIMETICS, INC. | Pharmaceuticals: Major | General Counsel | |
Scorpion Therapeutics, Inc.
 Scorpion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Scorpion Therapeutics, Inc. provides health care services. The company is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Director/Board Member | |
| Georgetown University | College/University | Undergraduate Degree | |
EcoR1 Capital, LLC
 EcoR1 Capital, LLC Investment ManagersFinance EcoR1 Capital LLC (EcoR1) is an independent registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded by Oleg Nodelman in 2012. EcoR1 serves as the general partner of and investment adviser to investment funds and provides investment advice to separate account clients. | Investment Managers | Chief Executive Officer | |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | General Counsel | |
| PANACEA ACQUISITION CORP. II | Financial Conglomerates | Chief Executive Officer | |
BVF Partners LP
 BVF Partners LP Investment ManagersFinance BVF Partners LP (BVF) is a SEC-registered investment advisor and hedge fund manager headquartered in San Francisco, California. The firm was founded in 1993 and is a subsidiary of BVF, Inc. BVF provides discretionary advisory services to private investment vehicles which includes commingled limited partnerships (the BVF Funds) and a limited liability entity organized for a single investor (Single Investor Fund) as well as to separately managed accounts. | Investment Managers | Corporate Officer/Principal | |
Biotechnology Value Fund LP
 Biotechnology Value Fund LP Investment ManagersFinance Part of BVF, Inc., Biotechnology Value Fund LP is an Alternative Investment Manager. The company is based in San Francisco, CA. | Investment Managers | Corporate Officer/Principal | |
| ANAPTYSBIO, INC. | Biotechnology | Director/Board Member | |
Aktis Oncology, Inc.
 Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member | |
Paratus Sciences Corp.
 Paratus Sciences Corp. BiotechnologyHealth Technology Paratus Sciences Corp. is an American company that focuses on unlocking the secrets of bat biology. The company's main goal is to elucidate novel insights and identify new therapeutic targets. The company was founded by Thomas Zwaka, Richard Young, Paul Matsudaira. The CEO is Amir H. Nashat. | Biotechnology | Director/Board Member | |
| EcoR1 Panacea Holdings LLC | Chief Executive Officer | ||
| McGill University | College/University | Doctorate Degree | |
Intrinsic Capital Partners
 Intrinsic Capital Partners Investment ManagersFinance Intrinsic Capital Partners is a private equity/venture capital firm founded by Gerald Stahlecker, Cornelius Merlini, and Howard Goodwin. The firm is headquartered in Conshohocken, Pennsylvania. | Investment Managers | Consultant / Advisor | |
| McNeil Consumer Products Co. | President | ||
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Harvard Medical School | College/University | Corporate Officer/Principal | |
| The Johns Hopkins University School of Medicine | College/University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 44 |
| Vereinigtes Königreich | 4 |
| Schweiz | 3 |
| Irland | 2 |
| Kanada | 2 |
Sektoral
| Health Technology | 31 |
| Consumer Services | 10 |
| Finance | 7 |
| Health Services | 3 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 134 |
| Corporate Officer/Principal | 67 |
| Independent Dir/Board Member | 45 |
| Chief Executive Officer | 30 |
| Chairman | 29 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Tony Vernon | 34 |
| Kathryn Falberg | 30 |
| Richard Scheller | 27 |
| David Hung | 24 |
| Daniel Welch | 24 |
| Kim Blickenstaff | 20 |
| Robert D. Mashal | 20 |
| Jonathan Lim | 18 |
| Oleg Nodelman | 15 |
| Thomas S. Templeman | 14 |
| Lisa V. DeLuca | 13 |
| Jennifer Fox | 13 |
| Michelle Doig | 12 |
| Robert Bazemore | 11 |
| Sergey Yurasov | 9 |
- Börse
- Insiders
- Moses Makunje
- Unternehmensverbindungen
